These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12868144)

  • 1. [The economics of managing patients with prostate cancer].
    Scattoni V; Lazzaro C; Rigatti P
    Arch Ital Urol Androl; 2003 Jun; 75(2):75-87. PubMed ID: 12868144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Managing patients with prostate cancer in Italy during the first year after diagnosis. A cost description based on a sample of 8 urological wards].
    Lazzaro C;
    Arch Ital Urol Androl; 2003 Sep; 75(3):138-49. PubMed ID: 14661392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review.
    Becerra V; Ávila M; Jimenez J; Cortes-Sanabria L; Pardo Y; Garin O; Pont A; Alonso J; Cots F; Ferrer M;
    BMC Health Serv Res; 2016 Oct; 16(1):541. PubMed ID: 27716267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].
    Becerra Bachino V; Cots F; Guedea F; Pera J; Boladeras A; Aguiló F; Suárez JF; Gallo P; Murgui L; Pont A; Cunillera O; Pardo Y; Ferrer M;
    Gac Sanit; 2011; 25(1):35-43. PubMed ID: 21316126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer.
    Lyth J; Andersson SO; Andrén O; Johansson JE; Carlsson P; Shahsavar N
    Scand J Urol Nephrol; 2012 Feb; 46(1):19-25. PubMed ID: 21905981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.
    Laviana AA; Ilg AM; Veruttipong D; Tan HJ; Burke MA; Niedzwiecki DR; Kupelian PA; King CR; Steinberg ML; Kundavaram CR; Kamrava M; Kaplan AL; Moriarity AK; Hsu W; Margolis DJ; Hu JC; Saigal CS
    Cancer; 2016 Feb; 122(3):447-55. PubMed ID: 26524087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of active surveillance for localized prostate cancer.
    Kim S; Dall'Era MA; Evans CP
    Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4).
    Andersson SO; Andrén O; Lyth J; Stark JR; Henriksson M; Adami HO; Carlsson P; Johansson JE
    Scand J Urol Nephrol; 2011 Apr; 45(3):177-83. PubMed ID: 21265595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radical prostatectomy for men aged <56 years with prostate cancer. Cost of illness analysis].
    Herkommer K; Fuchs TA; Hautmann RE; Volkmer BG
    Urologe A; 2005 Oct; 44(10):1183-4, 1185-8. PubMed ID: 16021411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost comparison of robotic, laparoscopic, and open radical prostatectomy for prostate cancer.
    Bolenz C; Gupta A; Hotze T; Ho R; Cadeddu JA; Roehrborn CG; Lotan Y
    Eur Urol; 2010 Mar; 57(3):453-8. PubMed ID: 19931979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.
    Sanyal C; Aprikian AG; Cury FL; Chevalier S; Dragomir A
    Cancer; 2016 Apr; 122(7):1085-96. PubMed ID: 26828716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
    Reinhold T; Dornquast C; Börgermann C; Weißbach L
    Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing resources in the local treatment of prostate cancer: A summary of cost-effectiveness studies.
    Muralidhar V; Nguyen PL
    Urol Oncol; 2017 Feb; 35(2):76-85. PubMed ID: 27473636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.
    de Rooij M; Crienen S; Witjes JA; Barentsz JO; Rovers MM; Grutters JP
    Eur Urol; 2014 Sep; 66(3):430-6. PubMed ID: 24377803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer.
    Zeliadt SB; Etzioni RD; Penson DF; Thompson IM; Ramsey SD
    Am J Med; 2005 Aug; 118(8):850-7. PubMed ID: 16084177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
    Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
    Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.